{"role": "assistant", "content": null, "function_call": {"name": "get_risks", "arguments": "{\"risks\":[{\"Description\":\"Lack of effective vaccines for vector-borne diseases\",\"Impact\":\"Increased risk of disease transmission and outbreaks\",\"Mitigation\":\"Investment in research and development of effective vaccines, and implementation of alternative control methods\",\"Technologies\":\"Vaccine development, advanced vector control methods\",\"People\":\"General population, particularly in regions affected by vector-borne diseases\",\"Owner\":\"Government health agencies, pharmaceutical industry\"},{\"Description\":\"Complacency and lack of investment in vector control\",\"Impact\":\"Resurgence of vector-borne diseases leading to epidemics\",\"Mitigation\":\"Sustained and comprehensive vector control programs, investment in surveillance and monitoring\",\"Technologies\":\"Vector surveillance technologies, advanced control methods\",\"People\":\"General population, particularly in regions affected by vector-borne diseases\",\"Owner\":\"Government health agencies, international organizations\"},{\"Description\":\"Lack of political will and central coordination\",\"Impact\":\"Failure to effectively reduce disease incidence and control vectors\",\"Mitigation\":\"Advocacy, political support, cross-border collaboration, and substantial donations\",\"Technologies\":\"Advocacy tools, coordination platforms, cross-border collaboration tools\",\"People\":\"Government officials, international organizations, advocacy groups\",\"Owner\":\"Government health agencies, international organizations, advocacy groups\"}]}"}}